- Home
- SUI vs UTHR Comparison
SUI vs UTHR Comparison
Compare SUI & UTHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SUI
- UTHR
- Stock Information
- Founded
- SUI 1975
- UTHR 1996
- Country
- SUI United States
- UTHR United States
- Employees
- SUI N/A
- UTHR N/A
- Industry
- SUI Real Estate Investment Trusts
- UTHR Biotechnology: Pharmaceutical Preparations
- Sector
- SUI Real Estate
- UTHR Health Care
- Exchange
- SUI Nasdaq
- UTHR Nasdaq
- Market Cap
- SUI 17.2B
- UTHR 16.2B
- IPO Year
- SUI 1993
- UTHR 1999
- Fundamental
- Price
- SUI $121.88
- UTHR $360.48
- Analyst Decision
- SUI Buy
- UTHR Buy
- Analyst Count
- SUI 12
- UTHR 14
- Target Price
- SUI $137.75
- UTHR $370.86
- AVG Volume (30 Days)
- SUI 757.3K
- UTHR 257.5K
- Earning Date
- SUI 11-06-2024
- UTHR 10-30-2024
- Dividend Yield
- SUI 3.03%
- UTHR N/A
- EPS Growth
- SUI N/A
- UTHR 25.10
- EPS
- SUI 1.87
- UTHR 22.72
- Revenue
- SUI $3,185,600,000.00
- UTHR $2,756,200,000.00
- Revenue This Year
- SUI N/A
- UTHR $26.32
- Revenue Next Year
- SUI $2.83
- UTHR $10.37
- P/E Ratio
- SUI $65.91
- UTHR $16.72
- Revenue Growth
- SUI 2.14
- UTHR 25.04
- 52 Week Low
- SUI $110.98
- UTHR $208.62
- 52 Week High
- SUI $147.83
- UTHR $417.82
- Technical
- Relative Strength Index (RSI)
- SUI 42.90
- UTHR 55.26
- Support Level
- SUI $121.13
- UTHR $358.82
- Resistance Level
- SUI $124.25
- UTHR $378.27
- Average True Range (ATR)
- SUI 2.35
- UTHR 8.13
- MACD
- SUI -0.06
- UTHR 0.71
- Stochastic Oscillator
- SUI 34.98
- UTHR 74.61
About SUI Sun Communities Inc.
Sun Communities is a residential REIT that focuses on owning manufactured housing, residential vehicle communities, and marinas. The company currently owns a portfolio of 666 properties, which includes 351 manufactured housing communities, 179 residential vehicle communities, and 136 marina properties. Sun targets owning properties that are desirable as second homes or vacation properties with nearly 50% of the portfolio located in either Florida or Michigan near major bodies of water.
About UTHR United Therapeutics Corporation
United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same molecule, treprostinil. Most of the company's sales are generated within the United States. United Therapeutics also markets a pediatric oncology drug, but its focus largely remains in pulmonary arterial hypertension.